Dr. Miles B. Conrad, MD

Dr. Conrad practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Conrad's NPI, 1831392083, was assigned on June 6, 2007. Dr. Conrad graduated from Geisel School Of Medicine At Dartmouth in 2001. Dr. Conrad holds California license A105381.

Dr. Conrad's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Conrad's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Conrad is also affiliated with Zuckerberg San Francisco General Hospital and Trauma Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Conrad to 1 more hospital and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Conrad practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Conrad's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Conrad is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Conrad's licenses on file in 3 states: California, Arizona and Washington.

CMS data shows 39 Medicare services from Dr. Conrad across 3 procedure codes in 2024, for 129 Medicare patients. Medicare paid $659 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 129 Medicare patients who saw Dr. Conrad in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 80% are also on Medicaid. Their average risk score is 4.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Conrad's median patient age at 62, with 46% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Conrad for performance year 2024, reported as part of a group. Dr. Conrad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Conrad as offering telehealth.

Dmand AI links 41 papers to Dr. Conrad, published from 2012 to 2024. 2020 was the busiest year, with 5. The most frequent topics are Telangiectasia, Hereditary Hemorrhagic, Embolization, Therapeutic and Biopsy. Dr. Conrad has published most often in J Vasc Interv Radiol. Dr. Conrad's most frequent co-authors are Mark W. Wilson, MD, Steven W. Hetts, MD and Daniel Lewis Cooke, MD.

Dmand AI links Dr. Conrad to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Epistaxis and Telangiectasia, Hereditary Hemorrhagic.

CMS Open Payments shows 159 general payments to Dr. Conrad from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Medtronic Vascular, Inc. paid the most, $30,604.

Dr. Conrad graduated from Geisel School Of Medicine At Dartmouth in 2001. Dr. Conrad is a member of SIR.

Dr. Conrad is in network with 4 carriers, including Elevance, United Healthcare and Blue Cross and Blue Shield of Kansas City. EPO plans come from the most carriers, 2. Check the plan with the practice before a visit.